Study reveals novel biomarkers for future dementia riskParticipants’ blood samples were drawn years before their dementia diagnosis.
The discovery is described in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.
One high-density lipoprotein (HDL) and one VLDL lipoprotein subclass were associated with increased dementia risk.
The altered metabolite signatures were observed years before the diagnosis of dementia when those study participants were healthy, Dr. Seshadri said.
“I hope that people reading about this study will understand that they can take ownership of their health,” Dr. Seshadri said.
Posts tagged as “Diagnostic”
The discovery is described in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.
Associations with lower, higher riskResearchers found that higher blood concentrations of molecules called branched-chain amino acids were associated with lower risk of future dementia.
One high-density lipoprotein (HDL) and one VLDL lipoprotein subclass were associated with increased dementia risk.
Diagnostic examIn the future, the Glenn Biggs Institute may investigate the feasibility of developing a diagnostic exam, such as a blood test, to assess each patient's molecular signature of dementia risk.
The altered metabolite signatures were observed years before the diagnosis of dementia when those study participants were healthy, Dr. Seshadri said.